Dr. Reddy’s wants to be India’s fifth largest drugmaker. What will it take?
The stock market has taken note of the company’s ambitious plans in the domestic market. But the path ahead is far from easy.
9 June, 2025•10 min
0
9 June, 2025•10 min
0
More in Business
Business
What to expect from Gulf public markets in 2026
Century Financial’s Arun Leslie John on why 2025 mattered—and what investors in the UAE and Saudi public markets should watch in the new year.
You may also like
Business
The weight-loss wave that’s changing India—one sector at a time
Mounjaro’s blockbuster debut has already sparked a seismic shift across Indian healthcare, diagnostics and pharma. A marked change in consumer behaviour looks imminent.
Health
Indian pharma exporters protesting against new regulations is not a good look
The rules require exporters of certain drugs to get an NOC from importing countries—a small but much-needed step to restoring India’s credibility in the global pharma market.
Business
News explainers that stood out in 2024
Bluesky vs X, the UAE deluge, Adar Poonawalla’s investment in Karan Johar’s Dharma Productions and more.
